Vaneck Biotech Etf Market Value

BBH Etf  USD 163.97  1.62  1.00%   
VanEck Biotech's market value is the price at which a share of VanEck Biotech trades on a public exchange. It measures the collective expectations of VanEck Biotech ETF investors about its performance. VanEck Biotech is trading at 163.97 as of the 22nd of November 2024. This is a 1.00 percent increase since the beginning of the trading day. The etf's open price was 162.35.
With this module, you can estimate the performance of a buy and hold strategy of VanEck Biotech ETF and determine expected loss or profit from investing in VanEck Biotech over a given investment horizon. Check out VanEck Biotech Correlation, VanEck Biotech Volatility and VanEck Biotech Alpha and Beta module to complement your research on VanEck Biotech.
Symbol

The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

VanEck Biotech 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VanEck Biotech's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VanEck Biotech.
0.00
12/03/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
11/22/2024
0.00
If you would invest  0.00  in VanEck Biotech on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding VanEck Biotech ETF or generate 0.0% return on investment in VanEck Biotech over 720 days. VanEck Biotech is related to or competes with Global X, Global X, Global X, and Global X. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index More

VanEck Biotech Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VanEck Biotech's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VanEck Biotech ETF upside and downside potential and time the market with a certain degree of confidence.

VanEck Biotech Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for VanEck Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VanEck Biotech's standard deviation. In reality, there are many statistical measures that can use VanEck Biotech historical prices to predict the future VanEck Biotech's volatility.
Hype
Prediction
LowEstimatedHigh
161.37162.41163.45
Details
Intrinsic
Valuation
LowRealHigh
146.12164.20165.24
Details
Naive
Forecast
LowNextHigh
155.43156.47157.51
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
157.40168.69179.98
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as VanEck Biotech. Your research has to be compared to or analyzed against VanEck Biotech's peers to derive any actionable benefits. When done correctly, VanEck Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in VanEck Biotech ETF.

VanEck Biotech ETF Backtested Returns

VanEck Biotech ETF owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the etf had a -0.14% return per unit of risk over the last 3 months. VanEck Biotech ETF exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VanEck Biotech's Coefficient Of Variation of (594.71), variance of 1.07, and Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide. The entity has a beta of 0.74, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, VanEck Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding VanEck Biotech is expected to be smaller as well.

Auto-correlation

    
  -0.24  

Weak reverse predictability

VanEck Biotech ETF has weak reverse predictability. Overlapping area represents the amount of predictability between VanEck Biotech time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VanEck Biotech ETF price movement. The serial correlation of -0.24 indicates that over 24.0% of current VanEck Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient-0.24
Spearman Rank Test-0.33
Residual Average0.0
Price Variance60.09

VanEck Biotech ETF lagged returns against current returns

Autocorrelation, which is VanEck Biotech etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VanEck Biotech's etf expected returns. We can calculate the autocorrelation of VanEck Biotech returns to help us make a trade decision. For example, suppose you find that VanEck Biotech has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

VanEck Biotech regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VanEck Biotech etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VanEck Biotech etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VanEck Biotech etf over time.
   Current vs Lagged Prices   
       Timeline  

VanEck Biotech Lagged Returns

When evaluating VanEck Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VanEck Biotech etf have on its future price. VanEck Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VanEck Biotech autocorrelation shows the relationship between VanEck Biotech etf current value and its past values and can show if there is a momentum factor associated with investing in VanEck Biotech ETF.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out VanEck Biotech Correlation, VanEck Biotech Volatility and VanEck Biotech Alpha and Beta module to complement your research on VanEck Biotech.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
VanEck Biotech technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of VanEck Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of VanEck Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...